Published in Gene Therapy Weekly, October 30th, 2003
"Since adenoviral p16(INK4A) gene transfer has shown limited promise in preclinical studies, we developed a strategy combining ionizing radiation (x-rays) with Ad-p16 gene therapy. Both radiation (2 Gy) and Ad-p16 alone demonstrated anti-tumor responses. The combination of radiation and Ad-p16 in vitro showed an augmented therapeutic response," scientists in the United States reported.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.